FDA Expands Use of Targeted Therapeutic for Lung Cancer
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
Tag: Targeted therapies
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
Last week, the U.S. Food and Drug Administration (FDA) approved the use of cobimetinib (Cotellic) in combination with vemurafenib...
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...